ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
H

ESMO 2021 Update on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC: Final Results From KEYNOTE-355

By ecancer FEATURING Hope Rugo
By ecancer FEATURING Hope Rugo
415 views
October 20, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Breast Cancers
06:33

EBCC 2024 Insights: "PRE-ACT Study - Evaluating AI Tool Prediction o…

ecancer

T. Rattay

11 views
05:19

EBCC 2024 Insights: "PREFERABLE-EFFECT Study - The Impact Exercise H…

ecancer

A. Hiensch

63 views
08:12

KEYNOTE-756 Trial - Adding Pembro to Chemo Before and After BC Surge…

ecancer

J. Cortes

339 views
23:30

Global Trends & Inequalities in BC Survival & Care

ecancer

C. Allemani, O. Ginsburg, V. Zadnik

13 views
15:48

Global Trends & Inequalities in BC Survival & Care: Panel Discussion

ecancer

C. Allemani, O. Ginsburg, V. Zadnik

8 views
13:08

The Latest Special Issue of Medical Science on the Use of Real-World…

ecancer

S. Kar

46 views
03:57

FABREC Study: Effectiveness of Short-Course Radiation vs. Standard T…

ecancer

J. Wong

66 views
22:07

Tailoring BC Treatments to Country Resources and Patients

ecancer

H. Earl

18 views
14:31

Tailoring BC Follow-Up Using Risk Predictions

ecancer

S. Siesling

91 views
06:01

TARGeted IORT INTRABEAM as a Treatment Option for Early Stage Breast…

ecancer

E. Sperk

14 views
06:38

Palbociclib Shows Improved PFS but Not Improved OS for ER+, HER2- mB…

ecancer

B. Gyawali

212 views
16:56

The RxPONDER Trial and Its Impact on Best Clinical Practice in HR+/H…

ecancer

C. Markopoulos, G. Curigliano

241 views
10:45

Tailoring Breast Cancer Radiation Therapy in the 21st Century

ecancer

P. Poortmans

202 views
12:45

ESMO 2021 Update on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC:…

ecancer

H. Rugo

415 views
13:54

Frontline Endocrine Therapy for Postmenopausal HR+, HER2- mBC: MONAL…

ecancer

G. Hortobagyi

697 views
04:16

ESMO 2021 Update on the Efficacy and Safety of [Vic-]Trastuzumab Duo…

ecancer

C. Saura

17 views
11:31

ESMO 2021: Summary of the Most Important Breast Cancer Trials

ecancer

M. Lambertini

129 views
09:32

BRCA Mutations mTNBC: Surveying Clinical Data of PARPi

ecancer

N. El Saghir

50 views
10:38

2020 ESMO Updates on BC: Atezo + (Nab-)Paclitaxel in Advanced TNBC, …

ecancer

B. Gyawali

306 views
09:17

Expert Analysis of Durvalumab + Olaparib/Paclitaxel in High-Risk HER…

ecancer

L. Pusztai

207 views
07:03

2020 ASCO Update on Newly Diagnosed mBC: Do Surgery and Radiation Af…

ecancer

S. Khan

109 views
05:40

2020 ESMO Update on Adjuvant CDK4/6i in Early HR+ BC: What Are the E…

ecancer

M. Lambertini

110 views
08:08

2020 ESMO Update on mTNBC: Is Sacituzumab Govitecan a Possible Stand…

ecancer

M. Lambertini

79 views
06:12

2020 ESMO Update on BC: Does Neoadjuvant Atezo/Chemo Combination Imp…

ecancer

M. Lambertini

150 views
07:14

2020 ESMO Update on ADCs in mTNBC: Is Sacituzumab Govitecan More Ben…

ecancer

A. Bardia

273 views